278 related articles for article (PubMed ID: 29745237)
1. Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis.
Glisic M; Shahzad S; Tsoli S; Chadni M; Asllanaj E; Rojas LZ; Brown E; Chowdhury R; Muka T; Franco OH
Eur J Prev Cardiol; 2018 Jul; 25(10):1042-1052. PubMed ID: 29745237
[TBL] [Abstract][Full Text] [Related]
2. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.
Mantha S; Karp R; Raghavan V; Terrin N; Bauer KA; Zwicker JI
BMJ; 2012 Aug; 345():e4944. PubMed ID: 22872710
[TBL] [Abstract][Full Text] [Related]
3. Progestin-only contraception and thromboembolism: A systematic review.
Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study.
Le Moigne E; Tromeur C; Delluc A; Gouillou M; Alavi Z; Lacut K; Mottier D; Le Gal G
Haematologica; 2016 Jan; 101(1):e12-4. PubMed ID: 26452982
[No Abstract] [Full Text] [Related]
5. Limited knowledge on progestogen-only contraception and risk of venous thromboembolism.
Bergendal A; Odlind V; Persson I; Kieler H
Acta Obstet Gynecol Scand; 2009; 88(3):261-6. PubMed ID: 19172422
[TBL] [Abstract][Full Text] [Related]
6. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
Han L; Jensen JT
Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
[TBL] [Abstract][Full Text] [Related]
8. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
Dragoman M; Curtis KM; Gaffield ME
Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraceptives and venous thromboembolism: an epidemiological update.
Plu-Bureau G; Maitrot-Mantelet L; Hugon-Rodin J; Canonico M
Best Pract Res Clin Endocrinol Metab; 2013 Feb; 27(1):25-34. PubMed ID: 23384743
[TBL] [Abstract][Full Text] [Related]
10. Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study.
Kurvits K; Laius O; Uusküla M; Laanpere M
Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):413-420. PubMed ID: 34160334
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progestin components of oral contraceptives: relationship to vascular disease.
Carr BR; Ory H
Contraception; 1997 May; 55(5):267-72. PubMed ID: 9220222
[TBL] [Abstract][Full Text] [Related]
12. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
[TBL] [Abstract][Full Text] [Related]
13. Progestin-only contraceptives: effects on weight.
Lopez LM; Ramesh S; Chen M; Edelman A; Otterness C; Trussell J; Helmerhorst FM
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008815. PubMed ID: 27567593
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive use and cardiovascular disease: is the relationship real or due to study bias?
Katerndahl DA; Realini JP; Cohen PA
J Fam Pract; 1992 Aug; 35(2):147-57. PubMed ID: 1386621
[TBL] [Abstract][Full Text] [Related]
15. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
Visser J; Snel M; Van Vliet HA
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD003990. PubMed ID: 23543528
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral contraceptive progestins on serum copper concentration.
Berg G; Kohlmeier L; Brenner H
Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Plu-Bureau G; Sabbagh E; Hugon-Rodin J
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
[TBL] [Abstract][Full Text] [Related]
18. Systemic hormonal contraception and risk of venous thromboembolism.
Heikinheimo O; Toffol E; Partonen T; But A; Latvala A; Haukka J
Acta Obstet Gynecol Scand; 2022 Aug; 101(8):846-855. PubMed ID: 35633036
[TBL] [Abstract][Full Text] [Related]
19. Progestin-only pills for contraception.
Grimes DA; Lopez LM; O'Brien PA; Raymond EG
Cochrane Database Syst Rev; 2013 Nov; (11):CD007541. PubMed ID: 24226383
[TBL] [Abstract][Full Text] [Related]
20. Risks and mechanisms of cardiovascular events in users of oral contraceptives.
Meade TW
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1646-52. PubMed ID: 3287935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
